17
Views
4
CrossRef citations to date
0
Altmetric
Original Experimental and Clinical Research

Tetracycline in Combination with Sodium Dioctylsulfosuccinate Show Increased Antimicrobial Activity in Resistant Microorganisms

Pages 38-44 | Published online: 18 Jul 2013

REFERENCES

  • Quintiliani R Jr, Sham DF, Courvalin P. Mechanism of resistance to antimicrobial agents. In PR Murray, EJ Baron, MA Pfaller, FC Tenover, RH Yolken (ed.), Manual of Clinical Microbiology, 7th ed. American Society for Microbiology, Washington, D.C. 1999: 1505–1525.
  • Altwegg M, Bockemuhl J. Escherichia and Shigella. In Topley & Wilson's. Systematic Bacteriology. Vol. 2. Microbiological and Microbiological Infections. A Balows and BI Duerden (ed.), 9th ed. Arnold London. 1998: 935–968.
  • Kavallaris M, Madafiglio J, Norris MD, Haber M. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by p-glycoprotein in human multidrug-resistant cells. Biochem Biophys Res Comm 1993; 190: 79–85.
  • Roberts MC. Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobil-ity, and distribution. FEMS Microb Rev 1996; 19: 1–24.
  • Argast M, Beck CF. Tetracycline diffusion through phospholipid bilayers and binding to phospholipids. Antimicrob Agents Chemother 1984; 26: 263–265.
  • Toyoda M, Morohashi M. An overview of topical antibiotics for acne treatment. Dermatology 1998; 196: 130–134.
  • Dougherty JM, McCulley JP, Silvany RE, Meyer DR. The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci. Invest Ophthalmol Vis Sci 1991; 32: 2970–2975.
  • Grippa E, Valla R, Battinelli L, Mazzanti G, Saso L, Silvestrini B. Inhibition of Candida rugosa Lipasi by berberine and structurally related alkaloids, evaluated by high-perfor-mance liquid chromatography. Biosci Biotechnol Biochem 1999; 63: 1557–1562.
  • Simonetti N, D'Auria FD, Strippoli V. Increased in vitro sensitivity of Candida albicans to fluconazole. Chemotherapy 1991; 37: 32–37.
  • Hugo WB, Russel AD. Evaluation of non-antibiotic antimicrobial agent. In Pharmaceutical Microbiology. London Blackwell Science Publ. Oxford Fifty Ed. 1993: 258.
  • Iwata K, Yamaguchi H. Anti Candida activity of clotrimazole in combination with dioctyl sodium sulfosuccinate and other surfactants. Antimicrob Agents Chemother 1997; 12: 206–212.
  • Shepherd MG, Poulter RTM, Sullivan PA. Candida albicans: biology, genetics, and pathogenicity. Ann Rev Microbiol 1985; 39: 579–614.
  • Simonetti G, Baffa S, Simonetti N. Contact imidazole activity against resistant bacteria and fungi. Int J Antimicrob Agents 2001; 17: 389–393.
  • D'Auria FD, Simonetti N, Strippoli V. Sodium dioctyl sulfosuccinate (SDSS) increases the sensitivity of Candida albicans to miconazole sulfosalicylate. Eur Bull Drug Res 1992; 1, 1.
  • D'Auria FD, Simonetti N, Strippoli V. Increased itra-conazole antifungal activity by agar diffusion test. J Microbiol Meth 1994; 20: 47–54.
  • Antley PP, Hazen KC. Role of yeast cell growth temperature on Candida albicans virulence in mice. Infect Immun 1988; 56: 2884–2890.
  • Monod M, Borg-von Zepelin M. In: Fungal Allergy and Pathogenicity. Ed. Breitenbach M, Crameri R, Lehrer SB, Karger Basel 2002: 114–128.
  • National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast; Approved Standard. M27-A. NCCLS, Wayne, PA, USA 1997.
  • National Committee for Clinical Laboratory Standards. Method for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically. Second Edition: Approved Standard M7-A2. NCCLS, Villanova, PA, USA, 1990.
  • European Standard EN1275: Chemical disinfectants and antiseptics. Basic fungicidal activity . Test method and requirements (Phase 1). CEN, Bruxelles 1997.
  • European Standard EN1276: Chemical disinfectants and antiseptics. Quantitative suspension test for the evaluation of bactericidal activity of chemical disinfectants and antiseptics used in food, industrial, domestic, and institutional areas. Test method and requirements (Phase 2. stepl). CEN, Bruxelles 1997.
  • Simonetti N, Strippoli V, Cassone A. Yeast mycelial conversion induced by N-acetyl-D-glucosamine in Candida albicans. Nature 1974; 250: 344–346.
  • Lindhal M, Faris A, Wadstrom T, Hjerten S. A new test based on “salting out” to measure relative surface hydropho-bicity of bacterial cells. Biochim Biophys Acta 1981; 677: 471–476.
  • Sud U, Feingold DS. Heterogeneity of action mechanisms among antimycotic imidazoles. Antimicrob Agents Chemother 1981; 20: 71–74.
  • Anderson ME. Determination of glutathione and glu-tathione disulfide in biological samples. Meth Enzymol 1985; 133: 548–555.
  • Odds FC. Candida and candidosis. A Review and Bibliography 2nd edn. Balliere Tindall, London, UK 1988.
  • Simonetti N, D'Auria FD, Strippoli V, Simonetti G. The inhibitory action of fluconazole on yeast-to-mycelial phase conversion in Candida albicans. Drug Invest 1992; 4: 15–19.
  • Reynard AM, Nellis LF. Uptake of tetracycline by Escherichia coli: lack of binding of tetracycline to the uptake system. Biochem Biophys Res Commun 1972; 48: 1129–1132.
  • Ha KC, White TC. Effects of azole antifungal drugs on the transition from yeast cells to hyphal in susceptible and resistant isolates of the pathogenic yeast Candida albicans. Antimicrob Agents Chemother 1999; 43: 763–768.
  • Guay CC, Rothstein DM. Expression of the TET K from Staphyloccoccus aureus in_Escherichia coli: comparison of substrate specificities of TET A (B), TET A (C), and TET K efflux proteins. Antimicrob Agents Chemother 1993; 37: 191–198.
  • Sgaragli G, Della Corte L, Rizzotti-Conti M, Giotti A. Effect of monocyclic compounds on biomembranes. Biochem Pharmacol 1997; 26: 2145–2149.
  • Chopra I, Ball P. Transport of antibiotics into bacteria. Adv Microb Physiol 1982; 23: 183–240.
  • Kaye SB. Clinical drug resistance: the role of factors other than P-glucoprotein. Am J Med 1995; 99: (suppl. 6 A) 40–44.
  • Palamara AT, Garaci E, Rotilio G, et al. Inhibition of murine aids by reduced gluthatione. AIDS Res Human Retro-viruses 1996; 12: 1373–1381.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.